406 related articles for article (PubMed ID: 27170000)
1. A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme.
Proietti M; Mairesse GH; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY;
Europace; 2016 Dec; 18(12):1779-1786. PubMed ID: 27170000
[TBL] [Abstract][Full Text] [Related]
2. Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme.
Proietti M; Mairesse GH; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY;
Eur J Prev Cardiol; 2017 Feb; 24(3):328-334. PubMed ID: 27909151
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme.
Proietti M; Farcomeni A; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY; Mairesse GH;
Eur J Prev Cardiol; 2019 Jun; 26(9):964-972. PubMed ID: 30935219
[TBL] [Abstract][Full Text] [Related]
4. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
5. A prospective 5-year follow-up after population-based systematic screening for atrial fibrillation.
Engdahl J; Holmén A; Rosenqvist M; Strömberg U
Europace; 2018 Nov; 20(FI_3):f306-f311. PubMed ID: 29688312
[TBL] [Abstract][Full Text] [Related]
6. Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study.
Svennberg E; Engdahl J; Al-Khalili F; Friberg L; Frykman V; Rosenqvist M
Circulation; 2015 Jun; 131(25):2176-84. PubMed ID: 25910800
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of atrial fibrillation in adults participating in a large-scale voluntary screening programme in Belgium.
Claes N; Van Laethem C; Goethals M; Goethals P; Mairesse G; Schwagten B; Nuyens D; Schrooten W; Vijgen J
Acta Cardiol; 2012 Jun; 67(3):273-8. PubMed ID: 22870733
[TBL] [Abstract][Full Text] [Related]
8. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
[TBL] [Abstract][Full Text] [Related]
9. Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination.
Kaasenbrood F; Hollander M; Rutten FH; Gerhards LJ; Hoes AW; Tieleman RG
Europace; 2016 Oct; 18(10):1514-1520. PubMed ID: 26851813
[TBL] [Abstract][Full Text] [Related]
10. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
[TBL] [Abstract][Full Text] [Related]
11. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
Shantsila E; Wolff A; Lip GY; Lane DA
Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
[TBL] [Abstract][Full Text] [Related]
12. Detection rate and treatment gap for atrial fibrillation identified through screening in community health centers in China (AF-CATCH): A prospective multicenter study.
Chen Y; Huang QF; Sheng CS; Zhang W; Shao S; Wang D; Cheng YB; Wang Y; Guo QH; Zhang DY; Li Y; Lowres N; Freedman B; Wang JG
PLoS Med; 2020 Jul; 17(7):e1003146. PubMed ID: 32673305
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
Lowres N; Neubeck L; Salkeld G; Krass I; McLachlan AJ; Redfern J; Bennett AA; Briffa T; Bauman A; Martinez C; Wallenhorst C; Lau JK; Brieger DB; Sy RW; Freedman SB
Thromb Haemost; 2014 Jun; 111(6):1167-76. PubMed ID: 24687081
[TBL] [Abstract][Full Text] [Related]
14. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
[TBL] [Abstract][Full Text] [Related]
16. Incremental yield of ECG screening repeated annually over 4 years in an adult Japanese population without prior atrial fibrillation: a retrospective cohort study.
Nagata Y; Yamagami T; Nutbeam D; Freedman B; Lowres N
BMJ Open; 2020 Jul; 10(7):e035650. PubMed ID: 32690510
[TBL] [Abstract][Full Text] [Related]
17. Predicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study.
Nasir JM; Pomeroy W; Marler A; Hann M; Baykaner T; Jones R; Stoll R; Hursey K; Meadows A; Walker J; Kindsvater S
Heart Rhythm; 2017 Jul; 14(7):955-961. PubMed ID: 28506913
[TBL] [Abstract][Full Text] [Related]
18. Systematic screening for atrial fibrillation in a 65-year-old population with risk factors for stroke: data from the Akershus Cardiac Examination 1950 study.
Berge T; Brynildsen J; Larssen HKN; Onarheim S; Jenssen GR; Ihle-Hansen H; Christophersen IE; Myrstad M; Røsjø H; Smith P; Tveit A
Europace; 2018 Nov; 20(FI_3):f299-f305. PubMed ID: 29095966
[TBL] [Abstract][Full Text] [Related]
19. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
